Overview
The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.
Eligibility
Inclusion Criteria:
- Men and women over 18, but not more than 75 years of age.
- Patients who have a regularly scheduled dermatology appointment for Intense Pulse Light (IPL), Pulse Dye Laser (PDL), or microneedling.
Exclusion Criteria:
- Any subject who has a previous history of allergy, sensitivity, and contraindication to benzocaine, lidocaine, or tetracaine.
- Patients with cardiac/respiratory disease, seizure disorder, or neuropathies.
- Patients who are under treatment for a dermatologic condition that may interfere with the evaluation of the study.
- Pregnant women and women who are breastfeeding.
- Patients who report concurrent use of anxiolytics or opiates, which may interfere with the interpretation of results.